• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Funding Roundup

Savara prices $113M offering

March 11, 2021 By Sean Whooley

Savara (NSDQ:SVRA) announced today that it priced an underwritten public offering of common stock at approximately $113 million. Austin, Texas–based Savara — an orphan lung disease treatment company with an inhaled formulation of recombinant human GM-CSF — is offering nearly 45.8 million shares of its common stock to the public at a price of $1.45 per […]

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup, Pharmaceutical Tagged With: Savara

Xeris Pharmaceuticals prices $27M offering

March 11, 2021 By Sean Whooley

Xeris Pharmaceuticals (NSDQ:XERS) announced today that it priced a registered direct offering of common stock at $27 million. Chicago-based Xeris is offering nearly 6.6 million shares of common stock to funds managed by Deerfield Management Company, which are existing investors in the company, according to a news release. Xeris develops technology platforms to enable ready-to-use, room-temperature […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Funding Roundup, Pharmaceutical Tagged With: xerispharmaceuticals

Neurelis closes $114M Series D for diazepam nasal spray

March 10, 2021 By Sean Whooley

Neurelis announced today that it closed a $114 million Series D financing round to support its lead orphan drug product. San Diego-based Neurelis’ Valtoco (diazepam nasal spray) is a proprietary formulation incorporating the science of Intravail transmucosal absorption enhancement technology. The drug enables the noninvasive delivery of a range of drugs, while the company focuses on […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Neurological, Pharmaceutical Tagged With: Neurelis Inc.

ForSight Robotics raises $10M for ophthalmic robotic surgery platform

March 9, 2021 By Sean Whooley

Forsight Robotics, a developer of a robotic surgical platform for ophthalmic procedures, has reportedly raised $10 million. According to a report from TechCrunch, the seed round of financing was led by Eclipse Ventures and Mithril Capital and is earmarked to be used for expanding the company’s headcount and global reach as it sets its sights […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Optical/Ophthalmic, Robotics, Surgical Tagged With: Forsight Robotics, robot-assisted, Robotic Surgery

Henry Schein reinstates share repurchase program

March 8, 2021 By Sean Whooley

Henry Schein (NSDQ:HSIC) announced today that it entered into amendments to reinstate its share repurchase program. Melville, N.Y.-based Henry Schein’s amendments to its private placement facility permit the company to reinstate the share repurchase program, according to a news release. The company said it had $201 million authorized and available for future stock repurchases at the […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Wall Street Beat Tagged With: Henry Schein

Private equity firm GTCR forms Epselon Global to acquire healthcare businesses

March 5, 2021 By Sean Whooley

GTCR announced that it entered into a Leaders Strategy partnership to form Epselon Global to acquire healthcare businesses. The private equity firm partnered with Michael Mulhern and Phil Macnabb to form the Chicago-based company centered around acquiring companies and assets as part of a strategy to build a market-leading healthcare business, according to a news […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Mergers & Acquisitions Tagged With: Epselon Global, gtcr

Pulmatrix completes $40M offering, updates product pipeline timetable

March 4, 2021 By Sean Whooley

Pulmatrix (NSDQ:PULM) announced today that it completed an offering with gross proceeds of approximately $40 million. Lexington, Mass.-based Pulmatrix said in a news release that it completed the registered direct offering to extend the company’s cash runway. Now, the company has additional financing to help fully fund data readouts across its development pipeline, which includes […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceutical, Research & Development Tagged With: Pulmatrix Inc.

PLx Pharma prices $63M offering

March 3, 2021 By Sean Whooley

PLx Pharma (NSDQ:PLXP) announced today that it priced an underwritten public offering worth approximately $63 million. Sparta, N.J.–based PLx Pharma is offering 7.875 million shares of its common stock priced at $8 per share to the public, according to a news release. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup Tagged With: PLx Pharma

MedTech 100 Roundup: Small slide continues

March 1, 2021 By Sean Whooley

On the back of several weeks of new records and strong performances, the medtech industry has finally hit a snag in its recent ascent. MassDevice‘s MedTech 100 index ended the week (Feb. 26) at 106.65 points, marking a 1.9% dip from the 108.72-point mark set one week before (Feb. 19). This highlights a similar drop from […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abiomed, iRhythm Technologies Inc., Medtronic, MiMedx Group Inc., Thermo Fisher Scientific, TransEnterix

ReWalk Robotics closes $40M private placement

February 26, 2021 By Sean Whooley

ReWalk Robotics (NSDQ:RWLK) announced today that it closed a private placement worth approximately $40 million. Marlborough, Mass.-based Rewalk Robotics’ private placement included more than 10.9 million ordinary shares and warrants to purchase up to nearly 5.5 million ordinary shares at a purchase price of $3.6625 per share and associated warrant, according to a news release. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Orthopedics, Robotics, Spine Tagged With: ReWalk Robotics

NuVasive reports mixed Q4 results

February 25, 2021 By Chris Newmarker

NuVasive (NASDAQ: NUVA) today reported Q4 earnings that beat the consensus forecast on Wall Street, but it came up short on revenue. The San Diego–based spine tech company earned $1.7 million, or 3¢ per share, on sales of $291.8 million for the three months ended Dec. 31, 2020, for a bottom-line drop of –94%  on […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Orthopedics, Spine Tagged With: Nuvasive

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 232
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS